Showing results (261-270 of 401) with videos related to

Sort By:
Pageof 41
Lab on a Chip|July 13, 2018
Quantitative and multiplex microRNA assays from unprocessed cells in isolated nanoliter well arraysAugusto M Tentori, Maxwell B Nagarajan, Jae Jung Kim, et al.
The Journal of Biological Chemistry|February 5, 1993
Independent binding of interleukin-1 alpha and interleukin-1 beta to type I and type II interleukin-1 receptorsJ Slack, C J McMahan, S Waugh, et al.
Annals of Human Genetics|October 1, 1991
Genetic epidemiology of ovarian cancer: segregation analysisR S Houlston, A Collins, J Slack, et al.
Annals of the New York Academy of Sciences|January 1, 1990
Molecular heterogeneity of interleukin-1 receptorsS K Dower, J E Sims, T H Stanton, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
A phase I study of meta-azidopyrimethamine ethanesulphonate (MZPES)--a new dihydrofolate reductase inhibitorN S Stuart, S M Crawford, G R Blackledge, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1989
Evidence for different interleukin 1 receptors in murine B- and T-cell linesK Bomsztyk, J E Sims, T H Stanton, et al.
Human Molecular Genetics|July 9, 2021
The SWI/SNF complex regulates the expression of miR-222, a tumor suppressor microRNA in lung adenocarcinomaPaola Peinado, Alvaro Andrades, Jordi Martorell-Marugán, et al.
Pharmaceutical Research|September 7, 2022
Simultaneous Targeting of Multiple oncomiRs with Phosphorothioate or PNA-Based Anti-miRs in Lymphoma Cell LinesKarishma Dhuri, Sai Pallavi Pradeep, Jason Shi, et al.
Angewandte Chemie (International Ed. in English)|September 26, 2017
An αv-RGD Integrin Inhibitor Toolbox: Drug Discovery Insight, Challenges and OpportunitiesRichard J D Hatley, Simon J F Macdonald, Robert J Slack, et al.
Molecular Therapy. Nucleic Acids|December 20, 2019
Hydrophobically Modified let-7b miRNA Enhances Biodistribution to NSCLC and Downregulates HMGA2 In VivoMeirav Segal, Annabelle Biscans, Maud-Emmanuelle Gilles, et al.
Pageof 41